@Biotech2050 @ActiniumPharma @SIERRATrial @ScienceAtBMS @JoeSzustakowski @JNJNews Doesn't seem like there ist interest by $JNJ. As a co. i would check that first or seek a partner that has interest and a CD38 mab.

Btw. : a radioactive-labeled nivolumab (IO) doesn't make sense at all.  Why do you come up with that?